SpaceX Turbine Push Unlikely to Threaten Howmet, Bernstein Says 
OpenAI Nears Astra AI Model Launch With Safety Focus 
Adobe Names Anil Chakravarthy CEO as AI Push Accelerates 
Lenovo Shares Fall After Dropbox Security Breach Exposes ID Vulnerability 
Fast Retailing Shares Drop as Uniqlo Japan August Sales Fall 
Shein Shares Drop 5% After Weak Hong Kong IPO Debut 
ByteDance Secures $29.6 Billion Loan to Boost AI Investment 
Anthropic IPO Marketing Expected to Start in Mid-October 
Volkswagen Approves 50,000 More Job Cuts in Major Restructuring 
Nvidia Eyes $2.5 Billion Investment in Thinking Machines Lab 
US Tech Giants’ AI Bond Boom Raises Euro Zone Borrowing Risks 
Audi, SAIC Launch China Innovation Hub for New AUDI Models 
Xiaomi Shares Jump on Europe EV Expansion Plan 
BP Names Ian Tyler Permanent Chairman After Governance Shake-Up 
MongoDB Stock Sinks 14% as Atlas Growth Misses Expectations 
Add as a preferred source on Google
The current state of the medical cannabis and cannabinoids use…
Achievements, Priorities, Trends, and Barriers
Toronto, Ontario, Feb. 26, 2018 -- The International Pharmaceutical Academy is pleased to announce its third upcoming Medicinal Cannabis Conference being held in Toronto, Canada at DoubleTree by Hilton Toronto Downtown on March 23 - 24, 2018.
This two-day conference will feature 10 of the world renowned experts from across North America including; Dr. Steven Laviolette from Schulich School of Medicine, Dr. Jahan Marcu from Americans for Safe Access Patient Focused Certification program, Dr. Philippe Lucas from The Canadian Medical Cannabis Council, Dr. Mark Lewis from NaPro Research, USA, Dr. Youbin Zheng, University of Guelph, and many more.
This conference will bring together a diverse range of professionals from wide range of research and development, medical, and cannabis industry experts who are directly involved; in Innovations in Cultivation, Processing, Cannabis Extraction, and Product Development of high quality and safe cannabis.
Among other topics, this event will create a forum to share results from ongoing efforts in understanding the use of cannabis (marijuana) for medical purposes in patients, cannabis substitution for opioids, alcohol, tobacco and other substances, and the current position by medical organizations on medical marijuana.
More information about the conference, including registration details, is
available at: http://www.ipacanada.com/CMH2018/index.html
Source: International Pharmaceutical Academy (IPA)
For further information: Media Contact: Rebecca Tan, Communications Co-ordinator, Direct line: (416) 410-7402, Fax: 1-888-236-5480, [email protected]
